Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nat Chem ; 15(1): 154, 2023 01.
Artículo en Inglés | MEDLINE | ID: mdl-36609646

Asunto(s)
Sacarosa , Gusto
2.
Colloids Surf B Biointerfaces ; 220: 112872, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36179611

RESUMEN

Fluorescent silica nanoparticles with a polymer shell of poly (D, L-lactide-co-glycolide) (PLGA) can provide traceable cell-triggered delivery of the anticancer drug doxorubicin (DOX), protecting the cargo while in transit and releasing it only intracellularly. PLGA with 50:50 lactide:glycolide ratio was grown by surface-initiated ring-opening polymerization (ROP) from silica nanoparticles of ca. 50 nm diameter, doped with a perylenediimide (PDI) fluorescent dye anchored to the silica structure. After loading DOX, release from the core-shell particles was evaluated in solution at physiological pH (7.4), and in human breast cancer cells (MCF-7) after internalization. The hybrid silica-PLGA nanoparticles can accommodate a large cargo of DOX, and the release in solution (PBS) due to PLGA hydrolysis is negligible for at least 72 h. However, once internalized in MCF-7 cells, the nanoparticles release the DOX cargo by degradation of the PLGA. Accumulation of DOX in the nucleus causes cell apoptosis, with the drug-loaded nanoparticles found to be as potent as free DOX. Our fluorescently traceable hybrid silica-PLGA nanoparticles with cell-triggered cargo release offer excellent prospects for the controlled delivery of anticancer drugs, protecting the cargo while in transit and efficiently releasing the drug once inside the cell.


Asunto(s)
Antineoplásicos , Nanopartículas , Humanos , Dióxido de Silicio , Doxorrubicina/farmacología , Doxorrubicina/química , Nanopartículas/química , Polímeros/química , Portadores de Fármacos/química
3.
Front Chem ; 8: 404, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32457878

RESUMEN

Thermally activated delayed fluorescence (TADF) molecules offer nowadays a powerful tool in the development of novel organic light emitting diodes due to their capability of harvesting energy from non-emissive triplet states without using heavy-metal complexes. TADF emitters have very small energy difference between the singlet and triplet excited states, which makes thermally activated reverse intersystem crossing from the triplet states back to the singlet manifold viable. This mechanism generates a long-lived delayed fluorescence component which can be explored in the sensing of oxygen concentration, local temperature, or used in time-gated optical cell-imaging, to suppress interference from autofluorescence and scattering. Despite this strong potential, until recently the application of TADF outside lighting devices has been hindered due to the low biocompatibility, low aqueous solubility and poor performance in polar media shown by the vast majority of TADF emitters. To achieve TADF luminescence in biological media, careful selection or design of emitters is required. Unfortunately, most TADF molecules are not emissive in polar media, thus complexation with biomolecules or the formation of emissive aggregate states is required, in order to retain the delayed fluorescence that is characteristic of these compounds. Herein, we demonstrate a facile method with great generalization potential that maintains the photophysical properties of solvated dyes by combining luminescent molecules with polymeric nanoparticles. Using an established swelling procedure, two known TADF emitters are loaded onto polystyrene nanoparticles to prepare TADF emitting nanomaterials able to be used in live-cell imaging. The obtained particles were characterized by optical spectroscopy and exhibited the desired TADF emission in aqueous media, due to the polymeric matrix shielding the dye from solvent polarity effects. The prepared nanoparticles were incubated with live human cancer cells and showed very low cytotoxicity and good cellular uptake, thus making fluorescence microscopy imaging possible at low dye concentrations.

4.
Mater Sci Eng C Mater Biol Appl ; 109: 110528, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32228970

RESUMEN

Thermally activated delayed fluorescence (TADF) has revolutionized the field of organic light emitting diodes owing to the possibility of harvesting non-emissive triplet states and converting them in emissive singlet states. This mechanism generates a long-lived delayed fluorescence component which can also be used in sensing oxygen concentration, measuring local temperature, or on imaging. Despite this strong potential, only recently TADF has emerged as a powerful tool to develop metal-free long-lived luminescent probes for imaging and sensing. The application of TADF molecules in aqueous and/or biological media requires specific structural features that allow complexation with biomolecules or enable emission in the aggregated state, in order to retain the delayed fluorescence that is characteristic of these compounds. Herein we demonstrate a facile method that maintains the optical properties of solvated dyes by dispersing TADF molecules in nanoparticles. TADF dye-doped silica nanoparticles are prepared using a modified fluorescein fluorophore. However, the strategy can be used with many other TADF dyes. The covalent grafting of the TADF emitter into the inorganic matrix effectively preserves and transfers the optical properties of the free dye into the luminescent nanomaterials. Importantly, the silica matrix is efficient in shielding the dye from solvent polarity effects and increases delayed fluorescence lifetime. The prepared nanoparticles are effectively internalized by human cells, even at low incubation concentrations, localizing primarily in the cytosol, enabling fluorescence microscopy imaging at low dye concentrations.


Asunto(s)
Colorantes Fluorescentes , Calor , Nanopartículas/química , Dióxido de Silicio , Colorantes Fluorescentes/química , Colorantes Fluorescentes/farmacología , Células HeLa , Humanos , Microscopía Fluorescente , Dióxido de Silicio/química , Dióxido de Silicio/farmacología
5.
Nanomaterials (Basel) ; 9(3)2019 Mar 26.
Artículo en Inglés | MEDLINE | ID: mdl-30917559

RESUMEN

Among a variety of inorganic-based nanomaterials, mesoporous silica nanoparticles (MSNs) have several attractive features for application as a delivery system, due to their high surface areas, large pore volumes, uniform and tunable pore sizes, high mechanical stability, and a great diversity of surface functionalization options. We developed novel hybrid MSNs composed of a mesoporous silica nanostructure core and a pH-responsive polymer shell. The polymer shell was prepared by RAFT polymerization of 2-(diisopropylamino)ethyl methacrylate (pKa ~6.5), using a hybrid grafting approach. The hybrid nanoparticles have diameters of ca. 100 nm at pH < 6.5 and ca. 60 nm at pH > 6.5. An excellent control of cargo release is achieved by the combined effect of electrostatic interaction of the cargo with the charged silica and the extended cationic polymer chains at low pH, and the reduction of electrostatic attraction with a simultaneous collapse of the polymer chains to a globular conformation at higher pH. The system presents a very low (almost null) release rate at acidic pH values and a large release rate at basic pH, resulting from the squeezing-out effect of the coil-to-globule transition in the polymer shell.

6.
ACS Med Chem Lett ; 9(1): 2-3, 2018 Jan 11.
Artículo en Inglés | MEDLINE | ID: mdl-29348801

RESUMEN

A shocking state of affairs; the use of nanoparticles as simple carriers is dead and outdated. Stimuli-responsive nanoparticles have emerged as active participants in the therapeutic landscape, rather than inert molecule carriers. And this time they are here to join the ongoing war against an old enemy: bacteria.

7.
Mater Sci Eng C Mater Biol Appl ; 80: 771-784, 2017 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-28866227

RESUMEN

Since the emergence of Nanotechnology in the past decades, the development and design of nanomaterials has become an important field of research. An emerging component in this field is nanomedicine, wherein nanoscale materials are being developed for use as imaging agents or for drug delivery applications. Much work is currently focused in the preparation of well-defined nanomaterials in terms of size and shape. These factors play a significantly role in the nanomaterial behavior in vivo. In this context, this review focuses on the toolbox of available methods for the preparation of polymeric nanoparticles. We highlight some recent examples from the literature that demonstrate the influence of the preparation method on the physicochemical characteristics of the nanoparticles. Additionally, in the second part, the characterization methods for this type of nanoparticles are discussed.


Asunto(s)
Nanopartículas , Sistemas de Liberación de Medicamentos , Nanomedicina , Nanotecnología , Polímeros
8.
Anal Chem ; 89(1): 681-687, 2017 01 03.
Artículo en Inglés | MEDLINE | ID: mdl-28105822

RESUMEN

Silica nanostructured materials are important in many fields, including catalysis, imaging, and drug delivery, mainly due to the versatility of surface functionalization that can bestow a huge variety of chemical and physical properties. With most applications requiring precise control over this surface modification, characterization of surface composition and reactivity have become of extreme importance. We present a novel approach to track silica surface modification and quantify functional group coverage using only solution NMR. We test the method using different types of silica nanoparticles and surface modifications, to show that after dissolving the silica matrix, the 1H NMR spectra can be resolved for every single component of the mixture. By using an internal standard, we are able to quantify the density of ligands and follow their sequential modification. Our work presents a fast, accurate, and straightforward method for surface characterization of silica nanostructures, using widely available NMR spectroscopy and small amounts of sample.

9.
ChemMedChem ; 10(1): 24-38, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25319803

RESUMEN

Nature continues to be the ultimate in nanotechnology, where polymeric nanometer-scale architectures play a central role in biological systems. Inspired by the way nature forms functional supramolecular assemblies, researchers are trying to make nanostructures and to incorporate these into macrostructures as nature does. Recent advances and progress in nanoscience have demonstrated the great potential that nanomaterials have for applications in healthcare. In the realm of drug delivery, nanomaterials have been used in vivo to protect the drug entity in the systemic circulation, ensuring reproducible absorption of bioactive molecules that do not naturally penetrate biological barriers, restricting drug access to specific target sites. Several building blocks have been used in the formulation of nanoparticles. Thus, stability, drug release, and targeting can be tailored by surface modification. Herein the state of the art of stimuli-responsive polymeric nanoparticles are reviewed. Such systems are able to control drug release by reacting to naturally occurring or external applied stimuli. Special attention is paid to the design and nanoparticle formulation of these so-called smart drug-delivery systems. Future strategies for further developments of a promising controlled drug delivery responsive system are also outlined.


Asunto(s)
Nanomedicina , Nanopartículas/química , Polímeros/química , Animales , Antineoplásicos/administración & dosificación , Antineoplásicos/química , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Preparaciones de Acción Retardada/administración & dosificación , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacología , Portadores de Fármacos/química , Humanos , Neoplasias/tratamiento farmacológico
10.
Carbohydr Res ; 402: 124-32, 2015 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-25498012

RESUMEN

The ubiquity of glycoconjugates in nature and their role in different biological processes, has led to the development of several methodologies to synthesize these molecules. Synthetic glycoconjugates are now used to answer a variety of glycoconjugate-related biological questions and have provided new potential vaccines against cancer, viral, and bacterial infections and new biotechnological tools. This review aims to collect and compile the recent advances in the field of glycopeptides, glycoproteins, and glycolipid synthesis and also to update the previous reviews made on this subject. Finally, by highlighting the successes and failures of past research, we hope that this review will inspire fruitful research in this important medicinal chemistry field.


Asunto(s)
Glicoconjugados , Técnicas de Química Sintética , Química Farmacéutica , Glicoconjugados/síntesis química , Glicoconjugados/química , Glucolípidos/síntesis química , Glucolípidos/química , Glicopéptidos/síntesis química , Glicopéptidos/química , Glicoproteínas/síntesis química , Glicoproteínas/química
11.
J Mater Chem B ; 2(25): 3946-3955, 2014 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-32261646

RESUMEN

Polymer-based nanomedicine is a large and fast growing field that has gained plenty of research attention during recent decades. In the present study, new amphiphilic polymers were designed and synthesized by chemical modification of poly(ethylene glycol) (PEG) conjugated with sucrose and a cholic acid moiety (abbreviated as Suc-PEG-Chol). Two series of polymers with different PEG chain lengths were synthesized and their structures were confirmed by 1H-NMR, 13C-NMR and MALDI-TOF analysis. The fluorescence spectroscopy data of these conjugates showed that they are able to self-assemble in water and the critical association concentration (CAC) value was found to be in the range of 0.06-0.13 g L-1. Owing to their amphiphilic characteristics in aqueous solution, polymeric nanoparticles (PNPs) of Suc-PEG-Chol polymers were prepared by a nanoprecipitation method without any surfactants. The particle size distribution was determined by dynamic light scattering (DLS) and the result was 117 nm for the Suc-PEG2000-Chol conjugate and 96 nm for the PEG4000 analog, both with relatively narrow particle size distribution. All of the obtained PNPs showed a negative surface charge and no size dependence on the polymer concentration forming stable nanoparticle suspensions. From the atomic force microscopy (AFM) and scanning electron microscopy (SEM) observations, the PNPs were spherically shaped with a relatively smooth surface. Our results suggest that these PEGylated nanoparticles formulated with cholic acid and sucrose as biocompatible building blocks can be considered a potential candidate for biomedical applications.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA